Swiss bank UBS has agreed to pay a $217 million (SFr233.5 million) settlement to US hospital operator HealthSouth following investor lawsuits related to fraud.
This content was published on
1 minute
The litigation came in the wake of an estimated $2.7 billion accounting fraud at the Alabama-based HealthSouth.
UBS insurers will pay $117 million to HealthSouth shareholders and $100 million to bondholders.
UK accounting firm Ernst & Young LLP has also agreed to pay a settlement of $33.5 million to the bondholders.
According to court documents, both UBS and Ernst & Young have denied any wrongdoing. The settlements require the approval of a US district judge.
Meanwhile, 15 former HealthSouth executives have pleaded guilty to involvement in a scheme to inflate earnings as well as the company’s share price.
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Legal action at UBS seen as “unlikely”
This content was published on
But Peter V. Kunz, a professor of economic law at Bern University told swissinfo.ch that Wednesday’s vote against the so-called discharge, usually a routine affair at annual general meetings, nevertheless has certain implications. The vote against – 52.8 per cent – has been widely interpreted as a strong signal of disapproval by the shareholders. UBS…
This content was published on
The investments occur despite the entry into force of the international treaty banning cluster munitions on August 1, groups claim. Switzerland, which formally signed the text in 2008, is expected to ratify it in 2011. “It’s unacceptable that our pension funds or the savings of the Swiss people are invested in producing weapons that kill…
This content was published on
At the bank’s annual general meeting on Wednesday, shareholders voted against exonerating the bank’s 2007 management, which includes former chairman Marcel Ospel, from all blame. The rebellion opens the door to possible civil or even criminal law suits. The Swiss bank’s current leadership had urged shareholders to clear their predecessors of blame following an internal…
This content was published on
Over the past few years, UBS has garnered a lot of negative press. Extraordinary general assemblies and public protests have been occuring with increasing frequency.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.